Chapter 1. Opioid Use Disorder Market – Scope & Methodology
1.1    Market Segmentation
1.2    Scope, Assumptions & Limitations
1.3    Research Methodology
1.4    Primary Sources
1.5    Secondary Sources 
Chapter 2. Opioid Use Disorder Market – Executive Summary
2.1    Market Size & Forecast – (2024 – 2030) ($M/$Bn)
2.2    Key Trends & Insights
            2.2.1    Demand Side
            2.2.2    Supply Side
2.3    Attractive Investment Propositions
2.4    COVID-19 Impact Analysis 
Chapter 3. Opioid Use Disorder Market – Competition Scenario
3.1    Market Share Analysis & Company Benchmarking
3.2    Competitive Strategy & Development Scenario
3.3    Competitive Pricing Analysis
3.4    Supplier-Distributor Analysis 
Chapter 4. Opioid Use Disorder Market Entry Scenario
4.1    Regulatory Scenario
4.2    Case Studies – Key Start-ups
4.3    Customer Analysis
4.4    PESTLE Analysis
4.5    Porters Five Force Model
            4.5.1    Bargaining Power of Suppliers
            4.5.2    Bargaining Powers of Customers
            4.5.3    Threat of New Entrants
            4.5.4    Rivalry among Existing Players
            4.5.5    Threat of Substitutes 
Chapter 5. Opioid Use Disorder Market – Landscape
5.1    Value Chain Analysis – Key Stakeholders Impact Analysis
5.2    Market Drivers
5.3    Market Restraints/Challenges
5.4    Market Opportunities 
Chapter 6. Opioid Use Disorder Market – By Drug 
6.1    Introduction/Key Findings   
6.2    Buprenorphine 
6.3    Sublocade
6.4    Belbuca
6.5    Suboxone 
6.6    Zubsolv
6.7    Methadone
6.8    Naltrexone
6.9    Y-O-Y Growth trend Analysis By Drug 
6.10    Absolute $ Opportunity Analysis By Drug , 2024-2030
Chapter 7. Opioid Use Disorder Market – By Route of Administration 
7.1    Introduction/Key Findings   
7.2    Intravenous
7.3    Oral
7.4    Y-O-Y Growth  trend Analysis By Route of Administration 
7.5    Absolute $ Opportunity Analysis By Route of Administration , 2024-2030
 Chapter 8. Opioid Use Disorder Market – By Age
8.1    Introduction/Key Findings   
8.2    19 to 40
8.3    41 to 60
8.4    61 & over
8.5    Y-O-Y Growth trend Analysis By Age
8.6    Absolute $ Opportunity Analysis By Age, 2024-2030
Chapter 9. Opioid Use Disorder Market – By Distribution Channel 
9.1    Introduction/Key Findings   
9.2    Hospital Pharmacies
9.3    Retail Pharmacies & Stores
9.4    Online Pharmacies
9.5    Y-O-Y Growth trend Analysis By Distribution Channel 
9.6    Absolute $ Opportunity Analysis By Distribution Channel , 2024-2030 
Chapter 10. Opioid Use Disorder Market, By Geography – Market Size, Forecast, Trends & Insights
10.1    North America
            10.1.1    By Country
                        10.1.1.1    U.S.A.
                        10.1.1.2    Canada
                        10.1.1.3    Mexico
            10.1.2    By Drug 
                        10.1.2.1    By Distribution Channel 
            10.1.3    By By Age
10.2    By Route of Administration 
            10.2.1    Countries & Segments - Market Attractiveness Analysis
10.3    Europe
            10.3.1    By Country
                        10.3.1.1    U.K
                        10.3.1.2    Germany
                        10.3.1.3    France
                        10.3.1.4    Italy
                        10.3.1.5    Spain
                        10.3.1.6    Rest of Europe
            10.3.2    By Drug 
            10.3.3    By Route of Administration 
            10.3.4    By By Age
            10.3.5    By Distribution Channel 
            10.3.6    Countries & Segments - Market Attractiveness Analysis
10.4    Asia Pacific
            10.4.1    By Country
                        10.4.1.1    China
                        10.4.1.2    Japan
                        10.4.1.3    South Korea
                        10.4.1.4    India      
                        10.4.1.5    Australia & New Zealand
                        10.4.1.6    Rest of Asia-Pacific
            10.4.2    By Drug 
            10.4.3    By Route of Administration 
            10.4.4    By By Age
            10.4.5    By Distribution Channel 
            10.4.6    Countries & Segments - Market Attractiveness Analysis
10.5    South America
            10.5.1    By Country
                        10.5.1.1    Brazil
                        10.5.1.2    Argentina
                        10.5.1.3    Colombia
                        10.5.1.4    Chile
                        10.5.1.5    Rest of South America
            10.5.2    By Drug 
            10.5.3    By Route of Administration 
            10.5.4    By By Age
            10.5.5    By Distribution Channel 
            10.5.6    Countries & Segments - Market Attractiveness Analysis
10.6    Middle East & Africa
            10.6.1    By Country
                        10.6.1.1    United Arab Emirates (UAE)
                        10.6.1.2    Saudi Arabia
                        10.6.1.3    Qatar
                        10.6.1.4    Israel
                        10.6.1.5    South Africa
                        10.6.1.6    Nigeria
                        10.6.1.7    Kenya
                        10.6.1.8    Egypt
                        10.6.1.9    Rest of MEA
            10.6.2    By Drug 
            10.6.3    By Route of Administration 
            10.6.4    By By Age
            10.6.5    By Distribution Channel 
            10.6.6    Countries & Segments - Market Attractiveness Analysis 
Chapter 11. Opioid Use Disorder Market – Company Profiles – (Overview, Product Portfolio, Financials, Strategies & Developments)
11.1    Alkermes
11.2    Indivior PLC
11.3    BioDelivery Sciences International
11.4    Orexo US
11.5    Titan Pharmaceuticals
11.6    Omeros Corporation
11.7    Camurus
11.8    Hikma Pharmaceuticals PLC
11.9    AstraZeneca plc
11.10    Viatris Inc